Press Release : Our preservative-free multidose eye dropper Novelia® approved for Santen’s Cosopt®

Press Release : Our preservative-free multidose eye dropper Novelia® approved for Santen’s Cosopt®

Nemera’s preservative-free multidose eye dropper Novelia® approved for Santen’s Cosopt® for Glaucoma treatments.


Santen announced that the preservative-free formulation Cosopt iMulti® will launch in 29 European countries in the coming months.


Nemera’s multidose eye dropper Novelia® has been approved for the preservative-free formulation Cosopt iMulti®

There is an innovation in glaucoma management by providing preservative-free medicines in multi-dose bottles to allow for effective and convenient, 24-hour intraocular pressure (IOP) control to glaucoma patients aged 18 or over.

“We are delighted to launch preservative-free multi-dose formulations of these glaucoma therapies in Europe,” said Luis Iglesias, Corporate Officer and Head of EMEA, Santen. “By providing highly effective and well-tolerated, preservative-free medicines, with the option for multi-dose bottles, we hope to empower patients in their daily lives and improve the management of their condition.”


“Patient adherence is the key for success for all treatments, especially silent chronic ophthalmic diseases. This is why, at Nemera, we developed an innovative system combining all patient needs: a safe preservative-free multi-dose bottle with a blue tip that makes consistent drops one by one” commented Fanny Sellier, Global Category Manager for Ophthalmic Products, Nemera.


The importance of preservative-free

The European Medicines Agency (EMA) outlines that preservatives should be avoided in patients who are on long-term treatment, or do not tolerate preserved eye drops.2 Switching from preserved to preservative-free topical ocular medications can diminish the harmful effects caused by preservatives.3 For example, switching to Cosopt® preservative-free improved local ocular tolerability for 85% of patients compared with their previous preserved medication


Key benefits of Novelia

  • 100% controlled and safe thanks to its patented PureFlow® Technology
  • Works with high viscosity suspensions, emulsions and solutions up to 1500cps
  • User-friendly and intuitive: easy eye targeting thanks to its blue tip feature, as easy to use as any standard eyedropper
  • One drop at a time into the patient’s eye
  • Calibrated drops providing a precise dose for a better treatment adherence


Novelia® will also be shown at differents events in the next months: Interphex, ARVO, FCE Pharma, CPhI China and CPhI Worldwide.



  • Download our full press release

  • About Nemera

    Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
    Nemera’s services and products cover several key delivery routes: Nasal/Buccal/Auricular (spray pumps, actuators, valves, etc.), Ophthalmic (preservative-free multidose eyedroppers), Pulmonary (pMDI, MDI’s, DPI’s), Dermal /Transdermal (airless & atmospheric dispensers), and Parenteral (autoinjectors, pens, and safety devices).

    Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer IP manufacturing.